Regal Investment Advisors LLC Werewolf Therapeutics, Inc. Transaction History
Regal Investment Advisors LLC
- $1.29 Billion
- Q2 2025
A detailed history of Regal Investment Advisors LLC transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Regal Investment Advisors LLC holds 27,204 shares of HOWL stock, worth $32,644. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,204
Previous 27,204
-0.0%
Holding current value
$32,644
Previous $26,000
11.54%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HOWL
# of Institutions
62Shares Held
23.3MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA6.68MShares$8.02 Million0.16% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.31MShares$5.17 Million10.84% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.41MShares$2.89 Million0.51% of portfolio
-
Bank Of America Corp Charlotte, NC2.13MShares$2.55 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.59MShares$1.91 Million0.0% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $35.4M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...